Predictions
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
20.02.22
20.02.22
€13.00
20.02.23
20.02.23
-
17.03.22
17.03.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€6.85
20.02.22
20.02.22
-
20.02.23
20.02.23
-14.37%
05.03.22
05.03.22
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.02
16.02.22
16.02.22
-
16.02.23
16.02.23
-10.26%
19.02.22
19.02.22
Could be worthwhile Investment >10% per year
Poxel S.A.
Start price
Target price
Perf. (%)
€4.07
15.02.22
15.02.22
€5.00
15.03.22
15.03.22
-25.36%
20.02.22
20.02.22
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€3.24
10.02.22
10.02.22
€3.80
10.02.23
10.02.23
-4.81%
11.02.23
11.02.23
Could be worthwhile Investment >10% per year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€7.83
09.02.22
09.02.22
-
09.02.23
09.02.23
-12.11%
18.02.22
18.02.22
Probably not worthwhile Investment
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€18.30
09.02.22
09.02.22
€20.00
09.03.22
09.03.22
-7.10%
10.03.22
10.03.22
Could be worthwhile Investment >10% per year
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€15.70
07.02.22
07.02.22
-
07.02.23
07.02.23
-60.50%
19.09.22
19.09.22
Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€6.22
06.02.22
06.02.22
-
06.02.23
06.02.23
-15.28%
20.02.22
20.02.22
Risky Investment
Molecular Templates Inc.
Start price
Target price
Perf. (%)
€2.53
06.02.22
06.02.22
-
06.02.23
06.02.23
-8.76%
20.02.22
20.02.22
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€15.03
05.02.22
05.02.22
€20.00
05.02.23
05.02.23
-57.41%
06.02.23
06.02.23
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Good culture
Could be very worthwhile Investment >20% year
BiondVax Pharmaceuticals Ltd ADR
Start price
Target price
Perf. (%)
€0.40
04.02.22
04.02.22
-
-
06.02.22
06.02.22
Risky Investment
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€56.78
04.02.22
04.02.22
€46.00
04.02.23
04.02.23
18.67%
13.10.22
13.10.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€56.78
04.02.22
04.02.22
€46.00
04.02.23
04.02.23
18.67%
13.10.22
13.10.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€56.78
04.02.22
04.02.22
€46.00
04.02.23
04.02.23
18.67%
13.10.22
13.10.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.04
02.02.22
02.02.22
-
02.02.23
02.02.23
-4.33%
06.02.22
06.02.22
Risky Investment
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€1.66
02.02.22
02.02.22
-
02.02.23
02.02.23
-3.83%
06.02.22
06.02.22
Risky Investment
Novavax Inc.
Start price
Target price
Perf. (%)
€87.29
01.02.22
01.02.22
-
01.02.23
01.02.23
-88.23%
02.02.23
02.02.23
Could be worthwhile Investment >10% per year
Fair valuation
Revenue growth >5% per year expected
Standard Investments for future growth
Innate Pharma
Start price
Target price
Perf. (%)
€3.51
01.02.22
01.02.22
€4.15
01.02.23
01.02.23
-7.69%
10.02.22
10.02.22
Could be worthwhile Investment >10% per year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.39
30.01.22
30.01.22
€4.00
30.01.23
30.01.23
-10.83%
14.03.22
14.03.22
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Epizyme Inc.
Start price
Target price
Perf. (%)
€1.10
27.01.22
27.01.22
€1.00
27.01.23
27.01.23
41.00%
05.02.22
05.02.22
Could be worthwhile Investment >10% per year
Capable Management
Bad culture
